Bioxyne lifts revenue 77% QoQ; Radiopharm listed on the Nasdaq in the December quarter; Tryptomine hits key milestones; Quarterly season is nearing its end, triggering a rush from ...

Nurix Therapeutics, Inc. (NASDAQ:NRIX), a biopharmaceutical company specializing in protein degradation therapies, has been ...

Sei Foundation launches $65M venture fund for DeSci startups, targeting innovations in wearables, data collectives, and drug discovery research.

Learn more about whether ACADIA Pharmaceuticals Inc. or Legend Biotech Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

VC, a venture capital firm that has spread its bets across multiple industries, including biotech and digital health, is ...

It was a busy week for the biotech sector, with regulatory and pipeline updates. Sage Therapeutics SAGE was in focus after it ...

Trouble sleeping is common in other neurodegenerative diseases, but past research has only suggested that it occurs in ...

In this Healio Video Perspective from Hawaiian Eye 2025, Greg Kunst, CEO of Aurion Biotech, discusses positive phase 1/2 data ...

Tony Locantro looks at a couple of ASX-listers showing some similarity upside when compared to much larger companies.

Iovance Biotherapeutics (NASDAQ: IOVA), a small-cap biotech company, has an innovative approach to treating cancer that relies on harnessing patients' cancer-fighting capabilities. Iovance's shares ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...